Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 11/20 | 0.66 |
| ▸ | RAB9A | P51151 | 11/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.63 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.63 |
| ▸ | RELA | Q04206 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10330362 | 0.98 | NPC1 (0.64) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL17991405 | 0.98 | NPC1 (0.64) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL12309408 | 0.95 | NPC1 (0.60) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL3293191 | 0.92 | NPC1 (0.75) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL2623780 | 0.92 | NPC1 (0.75) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL12354770 | 0.90 | NPC1 (0.66) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL12309409 | 0.90 | NPC1 (0.63) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL1104799 | 0.90 | NPC1 (0.72) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL6296907 | 0.90 | NPC1 (0.72) | NPC1RAB9AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL12427246 | 0.86 | NPC1 (0.68) | NPC1RAB9AKDM4ESMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9598450-B2 | Emissive compounds for organic light-emitting diodes | NITTO DENKO CORPORATION (JP) | 2017-03-21 | — | — | US | disclosed |
| US-9065055-B2 | Method for preparing doped organic semiconductor materials and formulation utilized therein | NOVALED AG (DE) | 2015-06-23 | — | — | US | disclosed |
| US-9065055-B2 | Method for preparing doped organic semiconductor materials and formulation utilized therein | NOVALED AG (DE) | 2015-06-23 | — | — | US | disclosed |
| EP-2008318-B1 | METHOD FOR PREPARING DOPED ORGANIC SEMICONDUCTOR MATERIALS | NOVALED AG (DE) | 2013-02-13 | — | — | EP | disclosed |
| US-20120261650-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-10-18 | — | — | US | disclosed |
| US-8264140-B2 | Organic electroluminescence element and display device | FUJI XEROX CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8264140-B2 | Organic electroluminescence element and display device | FUJI XEROX CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8102113-B2 | Quinoxaline-containing compounds and polymers thereof | FUJI XEROX CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8102113-B2 | Quinoxaline-containing compounds and polymers thereof | FUJI XEROX CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-7977864-B2 | Method and materials for patterning of an amorphous, non-polymeric, organic matrix with electrically active material disposed therein | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-07-12 | — | — | US | disclosed |
| US-20080069980-A1 | METHOD AND MATERIALS FOR PATTERNING OF AN AMORPHOUS, NON-POLYMERIC, ORGANIC MATRIX WITH ELECTRICALLY ACTIVE MATERIAL DISPOSED THEREIN | 3M INNOVATIVE PROPERTIES COMPANY | 2008-03-20 | — | — | US | disclosed |
| US-20080007166-A1 | METHOD AND MATERIALS FOR PATTERNING OF AN AMORPHOUS, NON-POLYMERIC, ORGANIC MATRIX WITH ELECTRICALLY ACTIVE MATERIAL DISPOSED THEREIN | 3M INNOVATIVE PROPERTIES COMPANY | 2008-01-10 | — | — | US | disclosed |
| US-20080007166-A1 | METHOD AND MATERIALS FOR PATTERNING OF AN AMORPHOUS, NON-POLYMERIC, ORGANIC MATRIX WITH ELECTRICALLY ACTIVE MATERIAL DISPOSED THEREIN | 3M INNOVATIVE PROPERTIES COMPANY | 2008-01-10 | — | — | US | disclosed |
| US-7276322-B2 | Transfer layer of amorphous, non-polymeric, organic matrix with a light emitting material disposed in the matrix is coated on a donor substrate; patterning using laser thermal transfer or thermal head transfer to produce electroluminescent device | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-10-02 | — | — | US | disclosed |
| US-7276322-B2 | Transfer layer of amorphous, non-polymeric, organic matrix with a light emitting material disposed in the matrix is coated on a donor substrate; patterning using laser thermal transfer or thermal head transfer to produce electroluminescent device | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-10-02 | — | — | US | disclosed |
| WO-2007107356-A1 | METHOD FOR PREPARING DOPED ORGANIC SEMICONDUCTOR MATERIALS AND FORMULATION UTILIZED THEREIN | NOVALED AG (DE) | 2007-09-27 | — | — | WO | disclosed |
| US-20070080634-A1 | THERMAL TRANSFER OF LIGHT-EMITTING DENDRIMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2007-04-12 | — | — | US | disclosed |
| US-20070080634-A1 | THERMAL TRANSFER OF LIGHT-EMITTING DENDRIMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2007-04-12 | — | — | US | disclosed |
| US-20070003783-A1 | Quinoline copolymer and organic electroluminescent device employing same | HITACHI CHEMICAL CO LTD (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20070003783-A1 | Quinoline copolymer and organic electroluminescent device employing same | HITACHI CHEMICAL CO LTD (JP) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120261650-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | EBPL, PAICS, CCNL2 | NPC1 4836/4885RAB9A 2931/4885KDM4E 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.